Dr Janet I Mcmahon, DO | |
80 B Veterans Blvd, Acoma, NM 87034 | |
(505) 552-5300 | |
(505) 552-5490 |
Full Name | Dr Janet I Mcmahon |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 80 B Veterans Blvd, Acoma, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669541785 | NPI | - | NPPES |
H3451 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | 192010 (New York) | Secondary |
207R00000X | Internal Medicine | 32610 (Georgia) | Primary |
Entity Name | Georgia Emergency Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528098290 PECOS PAC ID: 1052216389 Enrollment ID: O20031201000427 |
News Archive
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma.
Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.
Spain is leading the world in deceased organ donation. A new article published in the American Journal of Transplantation contains important information that can help other countries learn from the success of the Spanish system to help address the worldwide problem of transplant organ shortages.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Janet I Mcmahon, DO Po Box 130, San Fidel, NM 87049-0130 Ph: (505) 552-5300 | Dr Janet I Mcmahon, DO 80 B Veterans Blvd, Acoma, NM 87034 Ph: (505) 552-5300 |
News Archive
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma.
Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.
Spain is leading the world in deceased organ donation. A new article published in the American Journal of Transplantation contains important information that can help other countries learn from the success of the Spanish system to help address the worldwide problem of transplant organ shortages.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
› Verified 5 days ago